1216 related articles for article (PubMed ID: 17200718)
1. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.
Tacke F; Alvarez D; Kaplan TJ; Jakubzick C; Spanbroek R; Llodra J; Garin A; Liu J; Mack M; van Rooijen N; Lira SA; Habenicht AJ; Randolph GJ
J Clin Invest; 2007 Jan; 117(1):185-94. PubMed ID: 17200718
[TBL] [Abstract][Full Text] [Related]
2. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice.
Combadière C; Potteaux S; Rodero M; Simon T; Pezard A; Esposito B; Merval R; Proudfoot A; Tedgui A; Mallat Z
Circulation; 2008 Apr; 117(13):1649-57. PubMed ID: 18347211
[TBL] [Abstract][Full Text] [Related]
3. Spatio-temporal profile, phenotypic diversity, and fate of recruited monocytes into the post-ischemic brain.
Garcia-Bonilla L; Faraco G; Moore J; Murphy M; Racchumi G; Srinivasan J; Brea D; Iadecola C; Anrather J
J Neuroinflammation; 2016 Nov; 13(1):285. PubMed ID: 27814740
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis.
Gautier EL; Jakubzick C; Randolph GJ
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1412-8. PubMed ID: 19759373
[TBL] [Abstract][Full Text] [Related]
5. P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice.
An G; Wang H; Tang R; Yago T; McDaniel JM; McGee S; Huo Y; Xia L
Circulation; 2008 Jun; 117(25):3227-37. PubMed ID: 18519846
[TBL] [Abstract][Full Text] [Related]
6. Gas6 Promotes Inflammatory (CCR2
Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma triggers CCR2-independent monocyte entry into the brain during systemic infection by virulent Listeria monocytogenes.
Drevets DA; Dillon MJ; Schawang JE; Stoner JA; Leenen PJ
Brain Behav Immun; 2010 Aug; 24(6):919-29. PubMed ID: 20211719
[TBL] [Abstract][Full Text] [Related]
8. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury.
Li L; Huang L; Sung SS; Vergis AL; Rosin DL; Rose CE; Lobo PI; Okusa MD
Kidney Int; 2008 Dec; 74(12):1526-37. PubMed ID: 18843253
[TBL] [Abstract][Full Text] [Related]
9. Association of hydrogen sulfide with alterations of monocyte chemokine receptors, CCR2 and CX3CR1 in patients with coronary artery disease.
Gao L; Xu Z; Yin Z; Chen K; Wang C; Zhang H
Inflamm Res; 2015 Aug; 64(8):627-35. PubMed ID: 26123579
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression.
Rahman K; Vengrenyuk Y; Ramsey SA; Vila NR; Girgis NM; Liu J; Gusarova V; Gromada J; Weinstock A; Moore KJ; Loke P; Fisher EA
J Clin Invest; 2017 Aug; 127(8):2904-2915. PubMed ID: 28650342
[TBL] [Abstract][Full Text] [Related]
11. CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE(-/-) mice.
Aiello RJ; Perry BD; Bourassa PA; Robertson A; Weng W; Knight DR; Smith AH; Frederick KS; Kalgutkar A; Gladue RP
Atherosclerosis; 2010 Feb; 208(2):370-5. PubMed ID: 19837409
[TBL] [Abstract][Full Text] [Related]
12. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
[TBL] [Abstract][Full Text] [Related]
13. CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes.
Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Kim K; Eo SK
Immunology; 2016 Oct; 149(2):186-203. PubMed ID: 27260136
[TBL] [Abstract][Full Text] [Related]
14. CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice.
Jacquelin S; Licata F; Dorgham K; Hermand P; Poupel L; Guyon E; Deterre P; Hume DA; Combadière C; Boissonnas A
Blood; 2013 Aug; 122(5):674-83. PubMed ID: 23775714
[TBL] [Abstract][Full Text] [Related]
15. Discrepant Phenotyping of Monocytes Based on CX3CR1 and CCR2 Using Fluorescent Reporters and Antibodies.
Sommer K; Garibagaoglu H; Paap EM; Wiendl M; Müller TM; Atreya I; Krönke G; Neurath MF; Zundler S
Cells; 2024 May; 13(10):. PubMed ID: 38786041
[TBL] [Abstract][Full Text] [Related]
16. CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice.
Zhang Z; Dong J; Lobe CG; Gong P; Liu J; Liao L
Stem Cell Res Ther; 2015 Mar; 6(1):36. PubMed ID: 25889019
[TBL] [Abstract][Full Text] [Related]
17. Impact of deficiency in CCR2 and CX3CR1 receptors on monocytes trafficking in herpes simplex virus encephalitis.
Boivin N; Menasria R; Gosselin D; Rivest S; Boivin G
J Gen Virol; 2012 Jun; 93(Pt 6):1294-1304. PubMed ID: 22377584
[TBL] [Abstract][Full Text] [Related]
18. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway.
Barlic J; Zhang Y; Foley JF; Murphy PM
Circulation; 2006 Aug; 114(8):807-19. PubMed ID: 16908772
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.
Baeck C; Wei X; Bartneck M; Fech V; Heymann F; Gassler N; Hittatiya K; Eulberg D; Luedde T; Trautwein C; Tacke F
Hepatology; 2014 Mar; 59(3):1060-72. PubMed ID: 24481979
[TBL] [Abstract][Full Text] [Related]
20. Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization.
Cochain C; Rodero MP; Vilar J; Récalde A; Richart AL; Loinard C; Zouggari Y; Guérin C; Duriez M; Combadière B; Poupel L; Lévy BI; Mallat Z; Combadière C; Silvestre JS
Cardiovasc Res; 2010 Oct; 88(1):186-95. PubMed ID: 20501509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
